Skip to content

MBX Biosciences (MBX) IPO deck

MBX Biosciences is a clinical-stage biopharma company developing novel precision peptide therapies for endocrine and metabolic disorders.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest